1-7 of 7
Todd Rosenblat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thioguanine and decitabine can overcome hypomethylating agent resistance in patients with advanced myeloid malignancies

Free
Sunil Iyer, Joseph Jurcic, Daniel Lee, Mark Frattini, Monica Kasbekar, Alina Varabyeva, Azra Raza, Yi Chen, Rongjia Deng, Sebastian Fernando, Stefan Petkov, Simon Fredriksson, Aaron Viny, Todd Rosenblat
Journal: Blood
Blood (2025) 146 (Supplement 1): 3462.
https://doi.org/10.1182/blood-2025-3462
Published: 2025
Journal Articles

Favorable outcomes including post-transplant survival are seen independent of baseline skin burden in treatment-naïve patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with tagraxofusp (TAG): Subgroup analysis of a pivotal Trial

Free
Eunice Wang, Andrew Lane, Anthony Selwyn Stein, Sumithira Vasu, Todd Rosenblat, David Rizzieri, Marina Konopleva, John Katsetos, Alessandra Tosolini, Naveen Pemmaraju
Journal: Blood
Blood (2025) 146 (Supplement 1): 5221.
https://doi.org/10.1182/blood-2025-5221
Published: 2025
Journal Articles

Longitudinal single-cell spatial proteomics reveals predictive immune and stem cell signatures in Relapsed/Refractory AML

Free
Varun Sudunagunta, Stefan Petkov, Rongjia Deng, Yi Chen, Sebastian Fernando, Edna Stewart, Michele Simonetti, Sunil Iyer, Monica Kasbekar, Daniel Lee, Mark Frattini, Simon Fredriksson, Joseph Jurcic, Todd Rosenblat, Aaron Viny
Journal: Blood
Blood (2025) 146 (Supplement 1): 1696.
https://doi.org/10.1182/blood-2025-1696
Published: 2025
Journal Articles

Tagraxofusp Achieves Anti-Tumor Activity with Rapid Restoration of Normal Hematopoiesis in Treatment-Naïve Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Subanalysis of a Pivotal Trial

Free
Marina Konopleva, Naveen Pemmaraju, Kendra L. Sweet, Anthony S. Stein, David A. Rizzieri, Eunice S. Wang, Sumithira Vasu, Todd Rosenblat, Michael Zuurman, Ira Gupta, Andrew A. Lane
Journal: Blood
Blood (2024) 144 (Supplement 1): 1515.
https://doi.org/10.1182/blood-2024-200230
Published: 2024
Journal Articles

Acute Coagulopathy As an Underappreciated Toxicity of Azacitidine/Venetoclax Induction in AML

Free
Sunil G. Iyer, Aaron D. Viny, Alina Varabyeva, Todd Rosenblat, Joseph G Jurcic
Journal: Blood
Blood (2024) 144 (Supplement 1): 6072.
https://doi.org/10.1182/blood-2024-205177
Published: 2024
Journal Articles

A Phase I Trial of a Pharmacodynamically-Conceived Decitabine and Thioguanine Combination in Patients with Advanced Myeloid Malignancies

Free
Todd Rosenblat, MD, Mark L. Heaney, MD PhD, Joseph G Jurcic, MD, Azra Raza, MD, John G. Mears, MD, Ruth Santos, BS, Diana Carrillo, BS, David Shum, MS, Jacquelyn Gonzales, BSN, RN, Kevin Zikaras, BS, Martin Santos, BS, Rong Zhang, MS, Glorymar Ibanezs, MS, Leah Hogdal, BA, Jennifer Crombie, MD, Hakim Djaballah, PhD, Joseph M. Scandura, MD PhD, Anthony G. Letai, MD PhD, Mark G. Frattini, MD PhD
Journal: Blood
Blood (2014) 124 (21): 974.
https://doi.org/10.1182/blood.V124.21.974.974
Published: 2014
Journal Articles

Sequential Cytarabine and Alpha-Particle Immunotherapy with Bismuth-213 ( 213 Bi)-Labeled-HuM195 (Lintuzumab) for Acute Myeloid Leukemia (AML)

Free
Todd Rosenblat, MD, MS, Michael R. McDevitt, PhD, Deborah A. Mulford, MD, Neeta Pandit-Taskar, MD, Mark A. Weiss, MD, Mark L. Heaney, MD, PhD, Suzanne Chanel, RN, Alfred Morgenstern, PhD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD, Joseph G. Jurcic, MD
Journal: Blood
Blood (2008) 112 (11): 2983.
https://doi.org/10.1182/blood.V112.11.2983.2983
Published: 2008